The Physician's Guide to GLP-1 Medications: Semaglutide vs. Tirzepatide vs. Retatrutide

GLP-1 medications have become the biggest story in medicine since statins. Semaglutide, tirzepatide, retatrutide — if you've been anywhere near health news in the last two years, you've heard the names. But between the hype, the shortages, and the conflicting information online, most people still don't understand how these drugs actually work, how they differ, or which one might be right for them.

As a physician who prescribes GLP-1 medications daily, I wrote this guide to cut through the noise. No vendor links, no miracle claims — just the pharmacology, the real-world results, and what you should actually consider before starting treatment.

What Are GLP-1 Medications?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after eating. It does three things that matter for weight management:

• Signals satiety to your brain — you feel full sooner and stay full longer
• Slows gastric emptying— food moves through your stomach more slowly, extending that "satisfied" feeling
• Improves insulin sensitivity — your body handles blood sugar more efficiently, reducing cravings and energy crashes

GLP-1 receptor agonists are synthetic versions of this hormone, engineered to last much longer than the natural version (which breaks down in minutes). The result: sustained appetite regulation that makes it dramatically easier to maintain a caloric deficit without feeling like you're starving.

These are not "diet pills." They're peptide-based medications that work with your body's existing signaling systems. That's an important distinction — and it's why the results have been so consistent across clinical trials.

The Big Three: Semaglutide vs. Tirzepatide vs. Retatrutide

Three GLP-1 medications dominate the conversation right now. Each works differently, and understanding those differences matters for choosing the right one.

How They Compare: The Quick Reference

Beyond Weight Loss: What the Headlines Miss

The media narrative is almost entirely about weight loss. But GLP-1 medications are proving to have effects that go far beyond the scale:

This is why I tell patients: don't think of GLP-1 medications as "weight loss drugs." Think of them as metabolic optimization tools with broad systemic benefits. The weight loss is almost a side effect of getting your metabolic signaling right.

Side Effects: What to Actually Expect

Let's be honest about this. GLP-1 medications have real side effects, and you should know about them before starting.

Common (Most People Experience These)

• Nausea — the most common side effect, especially during dose titration. Usually improves significantly after 4-6 weeks. This is why slow titration matters.
• Reduced appetite— this is the mechanism of action, not a side effect. But it can be dramatic at first. Some patients forget to eat. Don't.
• GI discomfort — constipation, diarrhea, bloating. Usually mild and transient. Hydration and fiber help.
• Fatigue — common in the first few weeks as your body adjusts to lower caloric intake. Usually resolves.

Less Common but Important

• Muscle loss — a real concern with rapid weight loss. This is why physician supervision matters: we monitor body composition, not just weight, and adjust protein intake and exercise recommendations accordingly.
• "Ozempic face" — facial volume loss from significant weight reduction. Not unique to GLP-1s — it happens with any rapid weight loss. Manageable with slower titration and nutritional support.
• Gallbladder issues — rapid weight loss increases gallstone risk. Stay hydrated and report any right-sided abdominal pain.

Rare but Serious

• Pancreatitis — rare, but has been reported. Report severe, persistent abdominal pain immediately.
• Thyroid concerns — GLP-1 agonists carry a boxed warning for medullary thyroid carcinoma risk based on rodent studies. Human risk appears very low, but these medications are contraindicated if you have a personal or family history of MTC or MEN2.

The takeaway: most side effects are GI-related, dose-dependent, and improve with time. The key is slow, proper titration under medical supervision — which is exactly the thing you miss when you try to do this on your own.

What Physician-Supervised GLP-1 Therapy Looks Like

There's a spectrum of how people access these medications. Let me break it down honestly:

The difference matters more than people think. I've seen patients come to me after losing 40 pounds on semaglutide — but 15 of those pounds were muscle. With proper monitoring and protein optimization, that's preventable. Muscle loss during GLP-1 therapy is a solved problem when someone is actually paying attention.

Who Should Consider GLP-1 Therapy?

GLP-1 medications aren't for everyone, and they shouldn't be. Good candidates typically include:

• BMI ≥ 30 (or ≥ 27 with weight-related health conditions like type 2 diabetes, hypertension, or sleep apnea)
• People who have tried diet and exercise consistently but plateaued — these medications work best as part of a comprehensive approach, not a replacement for lifestyle changes
• Patients with metabolic syndrome, insulin resistance, or prediabetes — the metabolic benefits go beyond weight
• Anyone wanting to optimize body composition while preserving muscle mass — with proper supervision and training guidance

Not good candidates: people with a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or active eating disorders. Pregnant or planning pregnancy. People looking for a quick fix without willing to address underlying nutrition and activity habits.

The Oral GLP-1 Revolution

One of the most significant developments in GLP-1 therapy is the shift from injections to oral formulations. Oral semaglutide (Rybelsus) is already available, and next-generation oral GLP-1s like orforglipron are in late-stage development.

Why this matters:

• Removes the injection barrier — many patients are willing to take a pill but not a needle. This expands the treatable population significantly.
• Daily dosing vs. weekly — more consistent drug levels, potentially fewer GI side effects
• Lower cost potential — oral manufacturing is cheaper than injectable peptide production at scale
• Better adherence — pills are less likely to be missed or delayed compared to weekly injections

Orforglipron in particular is worth watching — Phase 3 data shows weight loss comparable to injectable semaglutide with oral-only dosing. When this reaches the market, we may see GLP-1 therapy become as routine as statin prescriptions.

Combining GLP-1s with Peptide Protocols

For patients already using peptides for other goals, the question often comes up: can I add a GLP-1 to my existing protocol?

The answer is usually yes — but with important caveats:

• GH secretagogues + GLP-1 — generally compatible and potentially synergistic. The GH support can help preserve lean mass during GLP-1-driven weight loss. CJC-1295/Ipamorelin + semaglutide is a combination I prescribe regularly.
• BPC-157 + GLP-1 — no known conflicts. BPC-157 may actually help with GI side effects given its gut-healing properties (though this is anecdotal, not proven in clinical trials).
• Tesamorelin + GLP-1 — an interesting combination for visceral fat. Tesamorelin targets visceral fat directly through GH release, while GLP-1 addresses overall metabolic regulation.

The key principle: the same stacking rules apply. Start one new compound at a time, monitor your response, and adjust from data — not guesswork.

What About the Cost?

Let's address the elephant in the room. Brand-name GLP-1 medications are expensive:

• Ozempic/Wegovy — $900-1,300/month without insurance
• Mounjaro/Zepbound — $1,000-1,200/month without insurance

This is why compounding pharmacies have become so important. Compounded semaglutide and tirzepatide — made with the same active ingredients by licensed pharmacies — are available at a fraction of the brand-name cost. Retatrutide, which isn't yet brand-name available, is accessible through compounding pharmacies under physician supervision.

Through a concierge practice like ours, patients typically access GLP-1 medications for significantly less than retail, with the added benefit of comprehensive physician oversight. The consultation, monitoring, and ongoing support are included — not billed separately per visit.

Getting Started: A Practical Roadmap

If you're considering GLP-1 therapy, here's what a responsible start looks like:

The Bottom Line

GLP-1 medications represent a genuine breakthrough in metabolic medicine. They're not magic — they work best when combined with proper nutrition, exercise, and medical oversight. But for the right patients, they can be transformative.

The most important decision isn't which GLP-1 to take — it's howyou access it. Physician supervision isn't a luxury; it's the difference between losing weight and losing weight safely while preserving the muscle mass, metabolic health, and nutritional status you'll need for the rest of your life.